As we announced on 15 October of this year, the MINTOTA research group was immersed in a new project for the validation, in relevant clinical environments, of the non-invasive monitoring tool Smart-Sens-H2S for chronic metabolic and cardiovascular pathologies.

In fact, the MINTOTA group continues with the validation tests of this tool in collaboration with the VALORTO-INVES group of the Faculty of Dentistry of the University of Valencia.

Now, MINTOTA has recruited personnel for the transfer and assessment of this Smart-Sens-H2S project. The new member, David Brines Colomar, Graduate and Master in Corporate Finance, joins the project in order to study the financial viability and the transfer of the Smart-Sens-H2S prototype derived from the patent P201160040. We continue to expand and broaden our knowledge horizons.